Pharmacogenomics (PGx) Level A Panel
A 16-gene pharmacogenomic panel based on CPIC Level A guidance for optimizing medication selection and dosing across cancer, cardiovascular, pain, and mental health conditions, powered by the Helix Exome+® platform.
Turnaround
6-9 days
Requery (SOQO)
≤ 5 minutes
Genes Tested
16
Panel Description
This test evaluates a patient’s metabolizer status for 16 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. All results in this test are based on CPIC Level A guidance, but this test is not comprehensive for all CPIC Level A guidance.
Order This Test
Contact our clinical team to order this panel or learn more.
Genes Tested
16 genes included in this panel
Ordering Information
Turnaround Time
Typically 6-9 days (standard), Typically ≤ 5 minutes (requery)
Preferred Specimen
BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit
Shipping Instructions
Specimens to arrive at Helix within 96 hours of collection at ambient temperature.
Clinical Description
This test evaluates a patient’s metabolizer status for 16 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. All results in this test are based on CPIC Level A guidance, but this test is not comprehensive for all CPIC Level A guidance.
Ready to order this test?
Contact our clinical team to order the Pharmacogenomics (PGx) Level A Panel for your patients.